Table 2 Performance Characteristics of MSIplus, Large-Panel NGS, and MSI-PCR in Prostate Cancer
From: Microsatellite instability in prostate cancer by PCR or next-generation sequencing
Assay | Sensitivity [95% CI] | Specificity [95% CI] |
|---|---|---|
MSIplus | 96.6% [80.4%–99.8%] | 100% [92.7%–100%] |
Large-Panel NGS | 93.1% [75.8%–98.8%] | 98.4% [90.2%–99.9%] |
MSI-PCR | 72.4% [52.5%–86.6%] | 100% [92.7%–100%] |